FATE vs. BFLY

Last updated Apr 1, 2026

Compare and contrast key facts about Fate Therapeutics, Inc. (FATE) and Butterfly Network, Inc. (BFLY).

Performance

FATE vs. BFLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fate Therapeutics, Inc. (FATE) and Butterfly Network, Inc. (BFLY). The values are adjusted to include any dividend payments, if applicable.

FATE vs. BFLY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
FATE Fate Therapeutics, Inc.	22.12%	-40.45%	-55.88%	-62.93%	-82.76%	-35.65%	173.80%
BFLY Butterfly Network, Inc.	6.32%	21.79%	188.89%	-56.10%	-63.23%	-66.20%	99.90%

Fundamentals

Market Cap FATE : $142.55M BFLY : $1.02B
EPS FATE : -$1.15 BFLY : -$0.31
PS Ratio FATE : 21.45 BFLY : 10.30
PB Ratio FATE : 0.69 BFLY : 5.21
Total Revenue (TTM) FATE : $6.65M BFLY : $97.61M
Gross Profit (TTM) FATE : $0.00 BFLY : $45.74M
EBITDA (TTM) FATE : -$147.70M BFLY : -$71.01M

Returns By Period

In the year-to-date period, FATE achieves a 22.12% return, which is significantly higher than BFLY's 6.32% return.

FATE

• 1D: 6.19%
• 1M: -18.92%
• YTD: 22.12%
• 6M: -4.76%
• 1Y: 51.88%
• 3Y*: -40.51%
• 5Y*: -57.03%
• 10Y*: -4.74%

BFLY

• 1D: 5.48%
• 1M: 6.60%
• YTD: 6.32%
• 6M: 109.33%
• 1Y: 77.19%
• 3Y*: 29.04%
• 5Y*: -24.32%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

FATE vs. BFLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FATE

FATE Risk / Return Rank: 62
FATE Sharpe Ratio Rank: 61
FATE Sortino Ratio Rank: 67
FATE Omega Ratio Rank: 61
FATE Calmar Ratio Rank: 62
FATE Martin Ratio Rank: 56

BFLY

BFLY Risk / Return Rank: 71
BFLY Sharpe Ratio Rank: 67
BFLY Sortino Ratio Rank: 78
BFLY Omega Ratio Rank: 72
BFLY Calmar Ratio Rank: 70
BFLY Martin Ratio Rank: 67

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FATE vs. BFLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fate Therapeutics, Inc. (FATE) and Butterfly Network, Inc. (BFLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	FATE	BFLY	Difference
Sharpe ratio Return per unit of total volatility	0.54	0.73	-0.19
Sortino ratio Return per unit of downside risk	1.48	1.97	-0.49
Omega ratio Gain probability vs. loss probability	1.17	1.23	-0.06
Calmar ratio Return relative to maximum drawdown	0.92	1.43	-0.50
Martin ratio Return relative to average drawdown	1.43	2.98	-1.55
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

FATE vs. BFLY - Sharpe Ratio Comparison

The current FATE Sharpe Ratio is 0.54, which is comparable to the BFLY Sharpe Ratio of 0.73. The chart below compares the historical Sharpe Ratios of FATE and BFLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	FATE	BFLY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.54	0.73	-0.19
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.63	-0.25	-0.38
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.06	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.15	-0.15	0.00

Correlation

The correlation between FATE and BFLY is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

FATE vs. BFLY - Dividend Comparison

Neither FATE nor BFLY has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

FATE vs. BFLY - Drawdown Comparison

The maximum FATE drawdown since its inception was -99.42%, roughly equal to the maximum BFLY drawdown of -97.40%. Use the drawdown chart below to compare losses from any high point for FATE and BFLY.

Drawdown Indicators

	FATE	BFLY	Difference
Max Drawdown Largest peak-to-trough decline	-99.42%	-97.40%	-2.02%
Max Drawdown (1Y) Largest decline over 1 year	-44.83%	-49.43%	+4.60%
Max Drawdown (5Y) Largest decline over 5 years	-99.29%	-95.90%	-3.39%
Max Drawdown (10Y) Largest decline over 10 years	-99.42%	—	—
Current Drawdown Current decline from peak	-98.98%	-85.11%	-13.87%
Average Drawdown Average peak-to-trough decline	-57.93%	-75.73%	+17.80%
Ulcer Index Depth and duration of drawdowns from previous peaks	28.97%	23.68%	+5.29%

Volatility

FATE vs. BFLY - Volatility Comparison

The current volatility for Fate Therapeutics, Inc. (FATE) is 20.41%, while Butterfly Network, Inc. (BFLY) has a volatility of 22.01%. This indicates that FATE experiences smaller price fluctuations and is considered to be less risky than BFLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FATE	BFLY	Difference
Volatility (1M) Calculated over the trailing 1-month period	20.41%	22.01%	-1.60%
Volatility (6M) Calculated over the trailing 6-month period	62.03%	85.38%	-23.35%
Volatility (1Y) Calculated over the trailing 1-year period	96.70%	106.84%	-10.14%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	90.52%	97.51%	-6.99%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	84.87%	95.29%	-10.42%

Financials